IP waiver won’t improve Africa’s access to Covid-19 shots: global drug makers
Multinational pharmaceutical companies have criticised the push by SA and India to introduce an intellectual property waiver on Covid-19 vaccines.
Multinational pharmaceutical companies have criticised the push by SA and India to introduce an intellectual property waiver on Covid-19 vaccines.
What's Your Reaction?
